EC Number | Application | Comment | Organism |
---|---|---|---|
6.1.1.1 | pharmacology | design of antimicrobial agents against Staphylococcus aureus, largely responsible for hospital-acquired infections, on the basis of knowledge of the crystal structure and the revealed catalytic mechanism | Staphylococcus aureus |
EC Number | Crystallization (Comment) | Organism |
---|---|---|
6.1.1.1 | crystal structure determination by X-ray diffraction, enzyme complexed with inhibitors at 2.8 A resolution, and truncated enzyme complexed with inhibitors at 2.2 A resolution | Staphylococcus aureus |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
6.1.1.1 | additional information | enzyme-inhibitor complexes | Staphylococcus aureus |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
6.1.1.1 | ATP + tyrosine + tRNATyr | Staphylococcus aureus | - |
AMP + Tyr-tRNATyr + diphosphate | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
6.1.1.1 | Staphylococcus aureus | - |
- |
- |
EC Number | Reaction | Comment | Organism | Reaction ID |
---|---|---|---|---|
6.1.1.1 | ATP + L-tyrosine + tRNATyr = AMP + diphosphate + L-tyrosyl-tRNATyr | mechanism | Staphylococcus aureus |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
6.1.1.1 | ATP + tyrosine + tRNATyr | - |
Staphylococcus aureus | AMP + Tyr-tRNATyr + diphosphate | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
6.1.1.1 | Tyrosine tRNA synthetase | - |
Staphylococcus aureus |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
6.1.1.1 | ATP | - |
Staphylococcus aureus |